Literature DB >> 5542709

Acyl transferase activities in dog lung microsomes.

M F Frosolono, S Slivka, B L Charms.   

Abstract

Mammalian lung has a high concentration of dipalmitoyl phosphatidylcholine and other phospholipids in which both fatty acid ester chains are saturated, as opposed to the usual asymmetric phospholipid (one saturated fatty acid and one unsaturated fatty acid). The acyl transferase system in dog lung microsomes was studied by determining the reactivities of various acyl CoA derivatives with 1-lyso-2-acyl- and 1-acyl-2-lyso-phosphatidylcholine. The 16:0 derivative had equal reactivity for both the 1- and 2-lyso positions. The 18:0 derivative also exhibited marked reactivity toward both positions, although the specific activity of the enzyme when palmitoyl CoA was used was approximately twice that compared to when stearoyl CoA was used. The 16:1 derivative showed approximately the same reactivity toward the 1-lyso position as did 16:0 but both 16:1 and 18:1 were more active with the 2-lyso position. These results suggest that acyl transferases may be important in the lung to insure that sufficient amounts of dipalmitoyl phosphatidylcholine will always be present for use in pulmonary surfactant biosynthesis. It is also conceivable that the acyl transferase system described acts on 1- and 2-lyso-palmitoyl phosphatidylcholine (produced by phospholipase hydrolysis of dipalmitoyl phosphatidylcholine) in order to produce phosphatidylcholine species needed for cellular purposes other than surfactant function.

Entities:  

Mesh:

Substances:

Year:  1971        PMID: 5542709

Source DB:  PubMed          Journal:  J Lipid Res        ISSN: 0022-2275            Impact factor:   5.922


  10 in total

1.  Changes in pulmonary surfactant and phosphatidylcholine metabolism in rats exposed to chrysotile asbestos dust.

Authors:  T D Tetley; R J Richards; J L Harwood
Journal:  Biochem J       Date:  1977-09-15       Impact factor: 3.857

2.  Increased incorporation of fatty acids into phospholipids of lungs and livers of rabbits under the influence of bromhexine and ambroxol.

Authors:  P von Wichert; U Bavendamm; M von Teichmann; G Müller; E Thalheim; A Wilke; U Wiegers
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1977-04       Impact factor: 3.000

3.  Synthesis of dipalmitoyl lecithin by alveolar macrophages.

Authors:  R J Mason; G Huber; M Vaughan
Journal:  J Clin Invest       Date:  1972-01       Impact factor: 14.808

4.  Incorporation of radioactive labelled cholin and palmitate into lung lecithin of rabbits treated with high doses of bromcarbamides, barbiturates and diazepam.

Authors:  P Wichert; C Schmidt; K Pomränke; U Wiegers
Journal:  Arch Toxicol       Date:  1977-06-18       Impact factor: 5.153

5.  Acyl CoA synthetase from rat lung: purification and properties.

Authors:  D K Das
Journal:  Lung       Date:  1982       Impact factor: 2.584

6.  Enzymes of phospholipid biosynthesis in rat alveolar type II cells.

Authors:  S K Hoehn; E Lesperance; D J Klass
Journal:  Lung       Date:  1983       Impact factor: 2.584

Review 7.  Perspectives on fetal lung development.

Authors:  R H Perelman; M J Engle; P M Farrell
Journal:  Lung       Date:  1981       Impact factor: 2.584

8.  Isolation and characterization of a membrane-associated, calcium-dependent phospholipase A2 from rabbit lung.

Authors:  R C Franson; D L Weir
Journal:  Lung       Date:  1982       Impact factor: 2.584

9.  Decreased dipalmitoyllecithin content found in lung specimens from patients with so-called shock-lung.

Authors:  P Wichert; F V Kohl
Journal:  Intensive Care Med       Date:  1977-04       Impact factor: 17.440

10.  Investigation of phospholipids of the pulmonary extracellular lining by electron paramagnetic resonance. The effects of phosphatidylglycerol and unsaturated phosphatidylcholines on the fluidity of dipalmitoyl phosphatidylcholine.

Authors:  G E Hook; J W Spalding; M J Ortner; E G Tombropoulos; C F Chignell
Journal:  Biochem J       Date:  1984-10-15       Impact factor: 3.857

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.